Table 3.

Proportion of participants with recurrent Pa by the number of cultures obtained during the follow-up period.

	EPIC Clinical Trial (N=304)	ESCF Historical Controls (N=608)
No. (%) with Recurrent Pa
Among those w/1 culture	0/6 (0%)	69/153 (45.1%)
Among those w/2 cultures	1/5 (20.0%)	79/148 (53.4%)
Among those w/3 cultures	1/10 (10.0%)	47/83 (56.6%)
Among those w/4+ cultures	102/277 (36.8%)	100/165 (60.6%)
Overall	104/298 (34.9%)	295/549 (53.7%)
95% CI	(29.7%,40.5%)	(49.6%,57.9%)
Overall Diff. as Compared
to Trial Participants	-	18.8%
95% CI	-	(11.9%,25.5%)
		p<0.001

CI= Confidence Interval; Diff = Difference